
Japanese encephalitis
The WHO website provides a list of certain diseases for which vaccines are available, and a list of some pathogens for which vaccines and/or monoclonal antibodies (mAbs) are in development. For each disease or pathogen, a link is provided to a...
- Category: Vaccines & delivery devices
- Organisation: WHO
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a protfolio of 12 vaccine-preventable diseases and further...
- Category: Vaccines & delivery devices
Cette note de synthèse actualisée sur les vaccins contre l’encéphalite japonaise (EJ) remplace la note de 2006 résumant la position de l’OMS sur le même sujet; elle renferme principalement des informations nouvelles concernant la...
- Category: Vaccines & delivery devices
More than 300 million people who live in rural areas of the Mekong region are among the most at-risk for Japanese encephalitis (JE) infection due to changes in the Mekong region’s ecological conditions. This fact sheet describes how PATH helps...
- Category: Service delivery
- Country: Viet Nam, Thailand, Myanmar, Lao People S Democratic Republic, Cambodia
- Organisation: PATH
Introduction: Two types of Japanese encephalitis (JE) vaccines, inactivated JE vaccine (JE-I) and live-attenuated JE vaccine (JE-L), are available and used in China. In particular, one JE-L, produced by a domestic manufacturer in China, was...
- Category: Service delivery
- Country: China
- Organisation: WHO
Background The performance of live attenuated Japanese Encephalitis SA 14-14-2 vaccine (CD-JEV) among children previously given inactivated mouse brain-derived JE vaccine (IMBV) is unknown. We evaluated the safety and immunogenicity of CD-JEV...
- Category: Service delivery
- Country: Sri Lanka
• Determining the costs and requirements to finance a new JE vaccination program is the final, essential step in deciding to introduce JE vaccine into a national immunization program. • Before introduction, countries should analyze and update...
- Category: Programme management
- Country: Not Specified
- Organisation: PATH
• WHO recommends that JE-endemic countries conduct a one-time JE vaccination campaign in the primary target population and then incorporate JE vaccine into the national immunization program (NIP) as routine immunization. • Routine immunization...
- Category: Programme management
- Country: Not Specified
- Organisation: PATH
• Three JE vaccines have been prequalified by WHO as safe, effective, and acceptable for procurement by United Nations agencies. • Vaccination programs using any of the WHO-prequalified JE vaccines would provide lifesaving protection from JE...
- Category: Vaccines & delivery devices
- Country: Not Specified
- Organisation: PATH
Forum Post
How to manage measles control? WHO-PATH's new e-Learning module
The Advanced Immunization Management (AIM) e-Learning website launched a new module on 7 October to support the World Health Organization's computer-based [b][url=http://aimstaging.path.org/en/measles
Forum Post
Temperature Monitoring Study To Commence in Vietnam and Uganda
[b]Temperature Monitoring Study To Commence in Vietnam and Uganda[/b] [i]by Joanie Robertson, Huong Vu and James Cheyne, PATH [/i]While some vaccines will lose their potency if they are stored at tem
Forum Post
New online tool for rotavirus vaccine decision-making
The Advanced Immunization Management (AIM) e-Learning website recently launched a new module to help decision-making on rotavirus vaccine introduction. The module provides comprehensi
Forum Post
POST 01372E: E-LEARNING MODULES—IMMUNIZATION FINANCING/ INT
POST 01372E: E-LEARNING MODULES—IMMUNIZATION FINANCING/ INTRODUCING NEW VACCINES 11 JANUARY 2009 ****************************************** Padmini, A useful introduction to the subject is
Forum Post
Post00370 GAVI UPDATE
Post00370 GAVI UPDATE 23 August2001 CONTENTS 1. GAVI INFORMATION UPDATE From: [[email protected]][email protected][/email] To: [[email protected]][email protected]
Forum Post
POST 00912E : JE VACCINE INTRODUCTION
POST 00912E : JE VACCINE INTRODUCTION 17 April 2006 ________________________________ Vikram Singh (mailto:[email protected]) from India, contributes some informa
Forum Post
POST 00398E - GAVI UPDATE
POST00398E GAVI UPDATE - 13 December 2001 Hemanthi Dassanayake from WHO kindly shared with us the following GAVI update of 13 December 2001 ___________________________________________________
Forum Post
Post00376 GAVI & VACCINE FUND INFO UPDATE
Post00376 GAVI & VACCINE FUND INFO UPDATE 21 September 2001 CONTENTS 1. INFORMATION UPDATE ON GAVI AND VACCINE FUND RELATED COUNTRY ACTIVITIES Visit the TechNet 21 Delhi meeti
Forum Post
Post00360 GAVI INFORMATION UPDATE
Post00360 GAVI INFORMATION UPDATE 24 July 2001 CONTENTS 1. UPDATE ON COUNTRY-LEVEL GAVI & GFCV RELATED ACTIVITIES 6 JULY 2001 From: [log in to unmask] To: [log in to unmask] Subject: Inf
Forum Post
Post00360 GAVI INFORMATION UPDATE
Post00360 GAVI INFORMATION UPDATE 24 July 2001 CONTENTS 1. UPDATE ON COUNTRY-LEVEL GAVI & GFCV RELATED ACTIVITIES 6 JULY 2001 From: [log in to unmask] To: [log in to unmask] Subject: Inf